National Institutes of Health
Basic Discoveries for Better Health
The Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) program was recently announced. Both a CTSA and a PGRN mentor are required. Read the FAQs here.
The Pharmacogenomics Knowledge Base (PharmGKB ) is an integrated knowledge base for pharmacogenomics linking phenotypes and genotypes.
The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists focused on understanding how a person’s genes affect his or her response to medicines. Funded since 2000, the PGRN has a Vision and Mission.
The following institutes contribute support to the Pharmacogenomics Research Network:NIGMS, NHLBI, NCI, NIDA, NICHD, NHGRI, NIMH, NIAMS, ORWH
Discover more about PGRN scientists, publications and governing structure.
Members and purpose of PGRN's scientific advisory panel.
Learn about partnerships between PGRN and global scientists.
Learn about PharmGKB projects with the scientific community.
View PGRN-related listings from the NIH Guide for Grants and Contracts, the official publication for NIH research grant policies, guidelines, and funding opportunities.
Read PGRN announcements and results.
Find articles and other news coverage featuring PGRN-supported advances.
Reach PGRN program staff.
Scientific Accomplishments and Background of the PGRN
Frequently Asked Questions about Pharmacogenetics
Personalized Medicines Fact Sheet
Map of Pharmacogenomics Research Network Members
How Medicines Work Fact Sheet
The Right FitMarch 2010 Findings feature article.
NIH Expands Network Focused on How Genes Affect Drug Responses
PGRN Logo